Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g.

作者: Junius Salendo , Melanie Spitzner , Frank Kramer , Xin Zhang , Peter Jo

DOI: 10.1016/J.RADONC.2013.06.032

关键词:

摘要: Abstract Background and purpose Preoperative chemoradiotherapy (CRT) represents the standard treatment for locally advanced rectal cancer. Tumor response progression vary considerably. MicroRNAs represent master regulators of gene expression, may therefore contribute to this diversity. Material methods Genome-wide microRNA (miRNA) profiling was performed 12 colorectal cancer (CRC) cell lines an individual in vitro signature chemoradiosensitivity established. Functional relevance selected miRNAs established by transfecting miRNA-mimics into SW480 SW837 cells. The prognostic value assessed 128 pretherapeutic patient biopsies. Results Thirty-six were identified significantly correlate with sensitivity CRT ( Q P =0.03). Conclusions This is first report a miRNA expression CRC lines. Many have not been linked potential molecular targets sensitize resistant cancers. If further validated, let7g serve as predictive biomarker.

参考文章(45)
Anjali K. Gupta, Vincent J. Bakanauskas, W. Gillies McKenna, Eric J. Bernhard, Ruth J. Muschel, Ras regulation of radioresistance in cell culture. Methods in Enzymology. ,vol. 333, pp. 284- 290 ,(2001) , 10.1016/S0076-6879(01)33063-X
Steven A. Eschrich, Jimmy Pramana, Hongling Zhang, Haiyan Zhao, David Boulware, Ji-Hyun Lee, Gregory Bloom, Caio Rocha-Lima, Scott Kelley, Douglas P. Calvin, Timothy J. Yeatman, Adrian C. Begg, Javier F. Torres-Roca, A Gene Expression Model of Intrinsic Tumor Radiosensitivity: Prediction of Response and Prognosis After Chemoradiation International Journal of Radiation Oncology Biology Physics. ,vol. 75, pp. 489- 496 ,(2009) , 10.1016/J.IJROBP.2009.06.014
William Ritchie, Stephane Flamant, John E J Rasko, Predicting microRNA targets and functions: traps for the unwary Nature Methods. ,vol. 6, pp. 397- 398 ,(2009) , 10.1038/NMETH0609-397
Qiong Li, Ge Wang, Jin-Lu Shan, Zhi-Xiang Yang, Hong-Zhong Wang, Jin Feng, Ji-Jun Zhen, Chuan Chen, Zhi-Min Zhang, Wen Xu, Xi-Zhong Luo, Dong Wang, MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. Journal of Gastroenterology and Hepatology. ,vol. 25, pp. 164- 171 ,(2010) , 10.1111/J.1440-1746.2009.05971.X
W Schmiegel, A Reinacher-Schick, D Arnold, U Graeven, V Heinemann, R Porschen, J Riemann, C Rödel, R Sauer, M Wieser, W Schmitt, H.-J Schmoll, T Seufferlein, I Kopp, C Pox, [Update S3-guideline "colorectal cancer" 2008]. Zeitschrift Fur Gastroenterologie. ,vol. 46, pp. 799- 840 ,(2008) , 10.1055/S-2008-1027726
Kyung Min Lee, Eun Jung Choi, In Ah Kim, microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling Radiotherapy and Oncology. ,vol. 101, pp. 171- 176 ,(2011) , 10.1016/J.RADONC.2011.05.050
Claus Rödel, Torsten Liersch, Heinz Becker, Rainer Fietkau, Werner Hohenberger, Torsten Hothorn, Ullrich Graeven, Dirk Arnold, Marga Lang-Welzenbach, Hans-Rudolf Raab, Heiko Sülberg, Christian Wittekind, Sergej Potapov, Ludger Staib, Clemens Hess, Karin Weigang-Köhler, Gerhard G Grabenbauer, Hans Hoffmanns, Fritz Lindemann, Anke Schlenska-Lange, Gunnar Folprecht, Rolf Sauer, German Rectal Cancer Study Group, None, Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncology. ,vol. 13, pp. 679- 687 ,(2012) , 10.1016/S1470-2045(12)70187-0
Martha L. Slattery, Abbie Lundgreen, Jennifer S. Herrick, Roger K. Wolff, Bette J. Caan, Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer Cancer. ,vol. 117, pp. 4175- 4183 ,(2011) , 10.1002/CNCR.26018
Vincenzo Valentini, Philippe Lambin, Robert J. Myerson, Is it time for tailored treatment of rectal cancer? from prescribing by consensus to prescribing by numbers Radiotherapy and Oncology. ,vol. 102, pp. 1- 3 ,(2012) , 10.1016/J.RADONC.2011.12.001